CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+16.29%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$7.82B
AUM Growth
+$7.82B
(+20%)
Cap. Flow
+$215M
Cap. Flow
% of AUM
2.74%
Top 10 Holdings %
Top 10 Hldgs %
19.27%
Holding
875
New
65
Increased
352
Reduced
239
Closed
80
Top Buys
| 1 |
Merck
MRK
|
$46.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
$29.1M |
| 3 |
Gilead Sciences
GILD
|
$27.9M |
| 4 |
BZUN
Baozun
BZUN
|
$26.6M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$26.5M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$81.1M |
| 2 |
Danaher
DHR
|
$31.9M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$28.1M |
| 4 |
Agilent Technologies
A
|
$28M |
| 5 |
McCormick & Company Non-Voting
MKC
|
$20.1M |
Sector Composition
| 1 | Healthcare | 33.36% |
| 2 | Technology | 16% |
| 3 | Financials | 11.25% |
| 4 | Consumer Discretionary | 8.98% |
| 5 | Communication Services | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Applied Materials
AMAT
$124B
| $28.4M | 0.36% |
688,129
-326,238
| -32% | -$13.5M |
|
|
SAGE
52
DELISTED
Sage Therapeutics
SAGE
| $28.4M | 0.36% |
178,300
+18,000
| +11% | +$2.86M |
|
53
IBM
IBM
$225B
| $28.2M | 0.36% |
187,546
-29,582
| -14% | -$4.44M |
|
54
Prudential Financial
PRU
$37.5B
| $27.4M | 0.35% |
279,855
+56,190
| +25% | +$5.49M |
|
55
Autodesk
ADSK
$68B
| $27.3M | 0.35% |
174,896
+11,464
| +7% | +$1.79M |
|
56
TJX Companies
TJX
$154B
| $26.7M | 0.34% |
475,022
+96,771
| +26% | +$5.44M |
|
57
Alnylam Pharmaceuticals
ALNY
$59B
| $26.6M | 0.34% |
284,701
| – | – |
|
|
BLUE
58
DELISTED
bluebird bio
BLUE
| $26.6M | 0.34% |
169,100
| – | – |
|
|
BZUN
59
Baozun
BZUN
$230M
| $26.6M | 0.34% |
+640,000
| New | +$26.6M |
|
60
Union Pacific
UNP
$131B
| $26.5M | 0.34% |
149,386
+8,331
| +6% | +$1.48M |
|
61
Wells Fargo
WFC
$259B
| $26.3M | 0.34% |
481,221
+3,625
| +0.8% | +$198K |
|
62
Neurocrine Biosciences
NBIX
$13.9B
| $25.8M | 0.33% |
292,669
+64,600
| +28% | +$5.69M |
|
63
Sherwin-Williams
SHW
$90.7B
| $25.5M | 0.33% |
59,169
+2,467
| +4% | +$1.06M |
|
64
3M
MMM
$81.3B
| $25.4M | 0.32% |
122,169
+31,888
| +35% | +$6.63M |
|
|
GG
65
DELISTED
Goldcorp Inc
GG
| $24.9M | 0.32% |
2,173,515
+1,699,002
| +358% | +$19.4M |
|
66
Allstate
ALL
$53.3B
| $24.6M | 0.31% |
247,971
-11,408
| -4% | -$1.13M |
|
67
Coca-Cola
KO
$296B
| $24.4M | 0.31% |
490,590
+165,729
| +51% | +$8.26M |
|
68
Texas Instruments
TXN
$178B
| $24.2M | 0.31% |
209,312
+65,643
| +46% | +$7.59M |
|
|
ONC
69
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.2B
| $24.2M | 0.31% |
183,232
+35,444
| +24% | +$4.68M |
|
70
Eli Lilly
LLY
$659B
| $23.5M | 0.3% |
181,004
+33,302
| +23% | +$4.32M |
|
|
71
Danaher
DHR
$144B
| $23.2M | 0.3% |
176,044
-241,270
| -58% | -$31.9M |
|
72
Credicorp
BAP
$20.7B
| $23M | 0.29% |
95,700
+7,400
| +8% | +$1.78M |
|
73
Sarepta Therapeutics
SRPT
$1.92B
| $23M | 0.29% |
192,600
+66,500
| +53% | +$7.93M |
|
|
RARX
74
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $22.9M | 0.29% |
1,024,000
+145,000
| +16% | +$3.25M |
|
75
Trimble
TRMB
$18.6B
| $22.8M | 0.29% |
565,070
-2,024
| -0.4% | -$81.8K |
|